Evaluation of Cerebral Oxygenation Results in Premature Infant

NCT04725435 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2023-04-18

No results posted yet for this study

Summary

The general purpose of this project is; Evaluation of cerebral oxygenation results in premature infants.

These results will be evaluated in two different applications. The first practice and the first sub-aim of the study is to determine the effect of kangaroo care on cerebral oxygenation (rSO2) in premature infants.

The second application and purpose is to determine the effect of giving the infant the facilitated tucking position by hand and the nesting bed on the cerebral oxygenation (rSO2) of the infant during the heel blood collection process.

The study will be conducted between December 2020 and December 2021 at Level III NICU at the Medical Faculty Hospital in Konya.

Conditions

  • Cerebral Oxygenation
  • Premature
  • Kangaroo Care
  • Facilitated Tucking

Interventions

BEHAVIORAL

Kangaroo care

Experimental: Kangaroo care The mother kangaroo will care for at least 60 minutes.

BEHAVIORAL

Facilitated Tucking Position

Experimental 1: Manual Facilitated Tucking Position, infants will be given a manual facilitated tucking position during the heel stick procedure. Experimental 2: Facilitated Tucking Position with the Nesting Bed (Tortoise Neo Bed), the facilitated tucking position will be given by the clinic nurse with the nesting bed during the heel stick collection procedure.

Sponsors & Collaborators

  • The Scientific and Technological Research Council of Turkey

    collaborator OTHER
  • Selcuk University

    lead OTHER

Principal Investigators

  • Fatma Tas Arslan, Prof · Selcuk University

  • Sibel Kucukoglu, assoc. prof. · Selcuk University

  • Deniz Kocoglu-Tanyer, assoc. prof. · Selcuk University

  • Hanifi Soylu, Prof · Selcuk University

  • Murat Konak, assoc. prof. · Selcuk University

  • Sevinc Akkoyun, Msc · Konya Ereğli State Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
24 Weeks
Max Age
37 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-20
Primary Completion
2021-10-20
Completion
2021-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04725435 on ClinicalTrials.gov